Bioinformatics prediction and experimental verification identify cuproptosis-related lncRNA as prognosis biomarkers of hepatocellular carcinoma

Cuproptosis is a form of cell death caused by intracellular copper excess, which plays an important regulatory role in the development and progression of cancers, including hepatocellular carcinoma (HCC), a prevalent malignancy with high morbidity and mortality.This study aimed to create a cuproptos...

Full description

Bibliographic Details
Published in:	Biochemistry and Biophysics Reports
Main Authors:	Zhu Liangyu, Zhang Bochao, Yin Guoquan, Zhang Yuan, Li Heng, Zhou Hanyu
Format:	Article
Language:	English
Published:	Elsevier 2023-09-01
Subjects:	Cuproptosis Hepatocellular carcinoma CAlncRNAs Prognostic model TCGA
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405580823000833

Similar Items

An integrative analysis revealing cuproptosis-related lncRNAs signature as a novel prognostic biomarker in hepatocellular carcinoma
by: Xilang Chen, et al.
Published: (2023-02-01)

Development and validation of cuproptosis-related lncRNA signatures for prognosis prediction in colorectal cancer
by: Lin Pang, et al.
Published: (2023-03-01)

Cuproptosis-related lncRNAs predict the clinical outcome and immune characteristics of hepatocellular carcinoma
by: Hongfei Zhu, et al.
Published: (2022-09-01)

Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response
by: Chong Li, et al.
Published: (2023-06-01)

Construction of lncRNA prognostic model related to cuproptosis in esophageal carcinoma
by: Liming Zhang, et al.
Published: (2023-04-01)

Cuproptosis-related lncRNA predicts prognosis and immune pathways in osteosarcoma patients
by: LIAO Jun, et al.
Published: (2024-08-01)

A cuproptosis-related lncRNA signature for predicting prognosis and immune response in hepatocellular carcinoma
by: Jingyi Wu, et al.
Published: (2023-09-01)

A novel prognostic model of breast cancer based on cuproptosis-related lncRNAs
by: Feixiang Li, et al.
Published: (2024-02-01)

Cuproptosis- and m6A-Related lncRNAs for Prognosis of Hepatocellular Carcinoma
by: Yuezhi Zhu, et al.
Published: (2023-08-01)

Analysis of novel therapeutic targets and construction of a prognostic model for hepatocellular carcinoma
by: Pengyuan Lei, et al.
Published: (2025-08-01)

Prediction of immune infiltration and prognosis for patients with cholangiocarcinoma based on a cuproptosis-related lncRNA signature
by: Hong-Fei Yao, et al.
Published: (2024-01-01)

Construction and systematic evaluation of a machine learning-based cuproptosis-related lncRNA score signature to predict the response to immunotherapy in hepatocellular carcinoma
by: Dingyu Lu, et al.
Published: (2023-01-01)

An 8-gene predicting survival model of hepatocellular carcinoma (HCC) related to pyroptosis and cuproptosis
by: Hongjin Wang, et al.
Published: (2023-07-01)

A cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinoma
by: Sheng Yu, et al.
Published: (2023-07-01)

Comprehensive analysis of cuproptosis-related lncRNAs in immune infiltration and prognosis in hepatocellular carcinoma
by: Chunhua Liu, et al.
Published: (2023-01-01)

A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for acute myeloid leukemia
by: Pian Li, et al.
Published: (2022-10-01)

Cuproptosis-related LncRNAs are potential prognostic and immune response markers for patients with HNSCC via the integration of bioinformatics analysis and experimental validation
by: Liuqing Zhou, et al.
Published: (2022-12-01)

Cuproptosis-related genes score: A predictor for hepatocellular carcinoma prognosis, immunotherapy efficacy, and metabolic reprogramming
by: Guilin Nie, et al.
Published: (2023-02-01)

Significance of cuproptosis‐related lncRNA signature in LUAD prognosis and immunotherapy: A machine learning approach
by: Lihong Yang, et al.
Published: (2023-06-01)

Relationships of Cuproptosis-Related Genes With Clinical Outcomes and the Tumour Immune Microenvironment in Hepatocellular Carcinoma
by: Xi Chen, et al.
Published: (2022-09-01)

Identification of the cuproptosis-related molecular subtypes and an immunotherapy prognostic model in hepatocellular carcinoma
by: Li Zhang, et al.
Published: (2022-11-01)

Combining immunogenic cell death and cuproptosis to construct a prognostic signature and predict the immune status and treatment efficacy for hepatocellular carcinoma
by: Xin Feng, et al.
Published: (2024-12-01)

Prediction of prognosis, immune infiltration, and personalized treatment of hepatocellular carcinoma by analysis of cuproptosis-related long noncoding RNAs and verification in vitro
by: Shanbao Li, et al.
Published: (2023-09-01)

A cuproptosis random forest cox score model-based evaluation of prognosis, mutation characterization, immune infiltration, and drug sensitivity in hepatocellular carcinoma
by: Ruiqi Liu, et al.
Published: (2023-03-01)

A novel cuproptosis-related prognostic gene signature and validation of differential expression in hepatocellular carcinoma
by: Yaoting Li, et al.
Published: (2023-01-01)

Identification and validation of a novel cuproptosis-related lncRNA signature for prognosis and immunotherapy of head and neck squamous cell carcinoma
by: Qiu-Shuang Xu, et al.
Published: (2022-11-01)

Bioinformatic analysis and experimental validation of cuproptosis-related LncRNA as a novel biomarker for prognosis and immunotherapy of oral squamous cell carcinoma
by: Shuang Liang, et al.
Published: (2024-02-01)

Development of prognostic model incorporating a ferroptosis/cuproptosis-related signature and mutational landscape analysis in muscle-invasive bladder cancer
by: Sida Hao, et al.
Published: (2024-08-01)

The cuproptosis related genes signature predicts the prognosis and correlates with the immune status of clear cell renal cell carcinoma
by: Peng Sun, et al.
Published: (2022-12-01)

Development and Validation of a Prognostic Signature Associated With Tumor Microenvironment Based on Autophagy-Related lncRNA Analysis in Hepatocellular Carcinoma
by: Yan Deng, et al.
Published: (2021-12-01)

The Role of Ferroptosis and Cuproptosis in Curcumin against Hepatocellular Carcinoma
by: Zhili Liu, et al.
Published: (2023-02-01)

Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma
by: Shengxian Xu, et al.
Published: (2022-07-01)

Cuproptosis‐related miRNAs signature and immune infiltration characteristics in colorectal cancer
by: Zhonglin Zhu, et al.
Published: (2023-08-01)

In Silico Identification and Validation of Cuproptosis-Related LncRNA Signature as a Novel Prognostic Model and Immune Function Analysis in Colon Adenocarcinoma
by: Yue Wang, et al.
Published: (2022-09-01)

Cuproptosis-related lncRNA signature for prognostic prediction in patients with acute myeloid leukemia
by: Yidong Zhu, et al.
Published: (2023-02-01)

A cuproptosis-related lncRNAs signature predicts prognosis and reveals pivotal interactions between immune cells in colon cancer
by: Jingru Song, et al.
Published: (2024-07-01)

Copper metabolism and cuproptosis: broad perspectives in the treatment of hepatocellular carcinoma
by: Jiale Liang, et al.
Published: (2025-07-01)

A novel cuproptosis-related prognostic signature and potential value in HCC immunotherapy
by: Xiang-Xu Wang, et al.
Published: (2022-09-01)

A newly defined cuproptosis-related model to predict prognosis and molecular docking highlights potentially therapeutic agents for hepatocellular carcinoma
by: Yong Pan, et al.
Published: (2024-03-01)

Identification of a novel prognostic cuproptosis-associated LncRNA signature for predicting prognosis and immunotherapy response in patients with esophageal cancer
by: Xinhai Sun, et al.
Published: (2024-05-01)